ID: ALA107371
Chembl Id: CHEMBL107371
PubChem CID: 9849471
Max Phase: Preclinical
Molecular Formula: C29H35N5O4
Molecular Weight: 517.63
Molecule Type: Protein
Associated Items:
Canonical SMILES: COC(=O)[C@H](Cc1ccc(C#Cc2ccccc2)cc1)NC(=O)CNC(=O)[C@H](N=C(N)N)C1CCCCC1
Standard InChI: InChI=1S/C29H35N5O4/c1-38-28(37)24(18-22-16-14-21(15-17-22)13-12-20-8-4-2-5-9-20)33-25(35)19-32-27(36)26(34-29(30)31)23-10-6-3-7-11-23/h2,4-5,8-9,14-17,23-24,26H,3,6-7,10-11,18-19H2,1H3,(H,32,36)(H,33,35)(H4,30,31,34)/t24-,26+/m0/s1
Standard InChI Key: GPTIUQHAKSANDO-AZGAKELHSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 517.63 | Molecular Weight (Monoisotopic): 517.2689 | AlogP: 1.63 | #Rotatable Bonds: 9 |
| Polar Surface Area: 148.90 | Molecular Species: BASE | HBA: 5 | HBD: 4 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
| CX Acidic pKa: 11.91 | CX Basic pKa: 10.56 | CX LogP: 2.90 | CX LogD: 0.73 |
| Aromatic Rings: 2 | Heavy Atoms: 38 | QED Weighted: 0.17 | Np Likeness Score: -0.30 |
| 1. Raimundo BC, Oslob JD, Braisted AC, Hyde J, McDowell RS, Randal M, Waal ND, Wilkinson J, Yu CH, Arkin MR.. (2004) Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions., 47 (12): [PMID:15163192] [10.1021/jm049967u] |
Source(1):
